David Osian Meredith
Has grant
Chief Scientific Officer
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
David Osian Meredith is the Chief Scientific Officer at PneumoWave in the United Kingdom. His research focuses on innovative solutions for overdose detection among high-risk opioid users, particularly through the development of wearable chest sensors. He is actively involved in studies aimed at enhancing safety and monitoring in supervised injecting facilities.
Recent Grants
Grant: Close
RESCU2 - Clinical Validation of Virtual Safe Drug Consumption Technology
Open Date: 2024-09-01
Close Date: 2025-08-01
Grant: Close
Advances in precision medicine for paediatric sleep disorders - Paediatric Advanced Respiratory Service (PARS) study
Open Date: 2023-08-31
Close Date: 2025-08-30
Grant: Close
RESpiratory monitoring reduCing drUg harm, the RESCU project
Open Date: 2021-09-19
Close Date: 2025-03-20
Grant: Close
Toxicity Alert Biosensor (TAB)
Open Date: 2018-12-01
Close Date: 2019-05-30
Articles (1)
Year:
2024
Collaborators (1)
Will Lawn
King’s College London
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.